Top 50 Health Care VC Funds & Investors in Finland (November 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Business Finland
VC Fund
|
23 | Finland, United States, United Kingdom | Grant, Seed, Debt Financing | Software, SaaS, Biotechnology | $52k–$6.6M |
|
Butterfly Ventures
VC Fund
|
20 | Finland, Sweden, Norway | Seed, Pre-Seed, Venture - Series Unknown | Software, Health Care, Information Technology | $110k–$6M |
|
Lifeline Ventures
VC Fund
|
19 | Finland, United States, United Kingdom | Seed, Series A, Venture - Series Unknown | Software, Health Care, Artificial Intelligence | $430k–$22M |
|
Tesi
VC Fund
|
18 | Finland, United States, Switzerland | Series A, Series B | Software, Manufacturing, Information Technology | $2.4M–$46M |
|
Finnvera Venture Capital
VC Fund
|
16 | Finland, United States, Chile | Seed, Venture - Series Unknown, Series A | Software, Health Care, Information Technology | $228k–$23M |
|
Innovestor
VC Fund
|
15 | Finland, Sweden, Denmark | Seed, Venture - Series Unknown, Pre-Seed | Software, Health Care, Information Technology | $204k–$5.1M |
|
Voima Ventures
VC Fund
|
14 | Finland, Sweden, Norway | Seed, Pre-Seed, Series A | Biotechnology, Health Care, Artificial Intelligence | $464k–$30M |
|
Icebreaker.vc
VC Fund
|
14 | Finland, Sweden, Estonia | Pre-Seed, Seed, Series A | Software, Information Technology, Artificial Intelligence | $110k–$25M |
|
Inventure
VC Fund
|
9 | Finland, Sweden, United States | Seed, Series A, Series B | Software, Information Technology, Artificial Intelligence | $549k–$25M |
|
Springvest
VC Fund
|
9 | Finland | Series A, Venture - Series Unknown, Seed | Biotechnology, Health Care, Medical | $1.6M–$53M |
|
Reaktor Ventures
VC Fund
|
8 | Finland, Germany, United States | Seed, Pre-Seed, Series A | Software, Internet, E-Commerce | $151k–$6.8M |
|
StartUp Health
VC Fund
|
8 | United States, Canada, United Kingdom | Seed, Venture - Series Unknown, Pre-Seed | Health Care, Medical, Wellness | $20k–$15M |
|
Redstone.VC
VC Fund
|
7 | Germany, Finland, Switzerland | Seed, Series A, Pre-Seed | Software, Information Technology, Artificial Intelligence | $460k–$17M |
|
Nordic Science Investments
VC Fund
|
6 | Finland, Sweden, Germany | Seed, Pre-Seed, Series A | Biotechnology, Medical, Health Diagnostics | $373k–$34M |
|
Visionplus
VC Fund
|
5 | Finland, United States, United Kingdom | Seed, Venture - Series Unknown, Series A | Software, Information Technology, Internet | $87k–$14M |
|
Almaral
VC Fund
|
5 | Finland | Seed, Convertible Note, Venture - Series Unknown | Medical Device, Health Diagnostics, Software | $832k–$2.9M |
|
Sitra
VC Fund
|
5 | Finland, The Netherlands | Venture - Series Unknown, Seed | Health Care, Biotechnology, CleanTech | $1.5M–$3.4M |
|
VTT Ventures
VC Fund
|
5 | Finland | Seed, Venture - Series Unknown, Series A | Manufacturing, Biotechnology, Electronics | $460k–$14M |
|
Maki.vc
VC Fund
|
4 | Finland, Norway, Denmark | Seed, Series A, Pre-Seed | Software, E-Commerce, Information Technology | $578k–$37M |
|
Novo Holdings
VC Fund
|
4 | United States, Denmark, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $9.5M–$135M |
|
Superhero Capital
VC Fund
|
4 | Finland, Lithuania, Estonia | Seed, Pre-Seed, Venture - Series Unknown | Software, Information Technology, Artificial Intelligence | $114k–$7.3M |
|
Oy Hammaren & Co Ab
VC Fund
|
4 | Finland | Venture - Series Unknown, Angel, Series A | Health Care, Wellness, GreenTech | $1.5M–$7.8M |
|
University of Helsinki
VC Fund
|
4 | Finland, Luxembourg, United States | Seed, Series A, Pre-Seed | Medical, Health Care, Biotechnology | $54k–$34M |
|
Nidoco
VC Fund
|
4 | Finland, Sweden, Estonia | Seed, Venture - Series Unknown, Pre-Seed | Software, SaaS, Artificial Intelligence | $327k–$60M |
|
Antler
VC Fund
|
4 | United States, Singapore, Australia | Pre-Seed, Seed, Series A | Software, Artificial Intelligence, Information Technology | $100k–$29M |
|
Novartis Venture Fund
VC Fund
|
4 | United States, Switzerland, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $5.1M–$107M |
|
HealthCap
VC Fund
|
3 | United States, Sweden, France | Series B, Series A | Biotechnology, Health Care, Medical | $6M–$92M |
|
M Ventures
VC Fund
|
3 | United States, United Kingdom, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $2.4M–$100M |
|
Pontos Group
VC Fund
|
3 | Finland, Estonia | Venture - Series Unknown, Seed | Apps, Mobile, Content | $6.3M–$16M |
|
Apteekkien Eläkekassa
VC Fund
|
3 | Finland | Venture - Series Unknown | Health Care | |
|
Takoa Invest
VC Fund
|
3 | Finland, Israel | Seed, Series B, Angel | Biotechnology, Mobile, Retail | $490k–$35M |
|
Athensmed
VC Fund
|
3 | Finland, Switzerland | Seed, Series A | Health Care, Health Diagnostics, Medical | $1.1M–$4.3M |
|
Gorilla Capital
VC Fund
|
3 | Finland, Sweden, Estonia | Pre-Seed, Seed, Venture - Series Unknown | Software, Information Technology, SaaS | $149k–$2.1M |
|
European Investment Bank
VC Fund
|
3 | France, Germany, Spain | Debt Financing, Post-IPO Debt, Venture - Series Unknown | Energy, Biotechnology, Health Care | $8.7M–$587M |
|
Cascara Ventures
VC Fund
|
3 | Germany, Finland, The Netherlands | Series A, Seed, Series B | Health Care, Biotechnology, Medical Device | $2M–$7.9M |
|
Lynx Capital
VC Fund
|
3 | Finland, United States | Series A, Venture - Series Unknown, Seed | Health Care, Medical, Biotechnology | |
|
Karolinska
VC Fund
|
3 | Sweden, Denmark, United States | Venture - Series Unknown, Seed | Biotechnology, Health Care, Pharmaceutical | $2.1M–$10M |
|
First Fellow Partners
VC Fund
|
3 | Finland, United States, Sweden | Seed, Series A, Pre-Seed | Software, SaaS, Information Technology | $256k–$26M |
|
Cor Group
VC Fund
|
3 | Finland | Seed, Pre-Seed, Series A | Health Care, Medical, Biotechnology | $2.3M–$8.7M |
|
Nostetta Ventures
VC Fund
|
3 | Finland | Seed, Pre-Seed | Health Care, Medical Device | $1.1M–$2.9M |
|
EISMEA
VC Fund
|
3 | Spain, Italy, United Kingdom | Grant, Venture - Series Unknown, Seed | Manufacturing, Biotechnology, Software | $53k–$2.6M |
|
Kinled Holding
VC Fund
|
2 | United Kingdom, United States, Switzerland | Seed, Series A | Biotechnology, Health Care, Software | $500k–$43M |
|
Illusian Founder Office
VC Fund
|
2 | Finland, United States, Germany | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $2.6M–$90M |
|
Stephen Industries
VC Fund
|
2 | Finland, Sweden | Seed, Series A, Pre-Seed | Software, Health Care, Biotechnology | $330k–$45M |
|
Creathor Ventures
VC Fund
|
2 | Germany, Switzerland, United States | Series A, Series B, Seed | Software, Health Care, Biotechnology | $1.1M–$30M |
|
Sofinnova Partners
VC Fund
|
2 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $7M–$105M |
|
Metsola Ventures
VC Fund
|
2 | Finland | Series A, Pre-Seed | Medical, mHealth, Automotive | $2.2M–$5.4M |
|
Broadview Ventures
VC Fund
|
2 | United States, Israel, Denmark | Series A, Seed, Debt Financing | Health Care, Biotechnology, Medical Device | |
|
Samsung Venture Investment
VC Fund
|
2 | South Korea, United States, India | Series A, Series B, Seed | Information Technology, Software, Health Care | $45k–$28M |
|
Tradeka
VC Fund
|
2 | Finland | Angel, Pre-Seed | Fruit, Gaming, Nutrition | |
| Access all 322 VC funds in Finland Health Care startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Business Finland finances business R&D projects and public research projects at universities, research institutes and universities of applied sciences. Read more about R&D and business funding.
Show more...Investment focus
- Industry: Software, SaaS, Biotechnology
- Stage:Grant, Seed, Debt Financing
- Geography: Finland, United States, United Kingdom
Investor stats
- Total investments: 247
- Round size: Seed $137k–$3.5M; Grant $52k–$6.6M; Debt Financing $252k–$6.5M
- Lead/follow: 43% lead, 57% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- STRGY AI — The strategy was never the problem. The evidence was correct, sitting in someone's hands, and it died anyway because nothing in the organization was built to carry that evidence from where it was seen to where it could be acted on, and keep it alive long enough to matter. Not a bad plan. Not bad people. A structural gap between signal andauthority that every existing tool — decks, dashboards, status meetings — is too static and too easy to ignore to actually close.STRGY exists because that gap is the default state of every organization above a certain size, and closing it has always required either a heroic individual repeating themselves for years or luck (the corporate pilot needed one person to remember "do not drop this" at the right moment, and no one did). That's not a strategy problem to solve with a better framework — it's an infrastructure problem. You need something that holds the signal, doesn't forget it, doesn't get bored repeating it, and resurfaces it automatically the moment the gap between evidence and action starts to widen. That's what a human can't do reliably at scale, and what software with real memory can.
- Coolbrook — Coolbrook is a manufacturer of naphtha cracking-based reactors. Their technology is intended to replace the conventional steam cracker furnace in existing and new olefins plants, enabling petrochemical clients to get improved product yield and lower energy consumption.
- Solar Foods — Solar Foods is a food-tech startup that specializes in testing a technology that uses electricity to produce hydrogen which is combined with carbon dioxide, water, vitamins, and minerals to feed and grow microbial biomass that can be used as edible protein. The industrial biotech startup develops a protein called Solein, a nutritious, sustainablesubstitute for animal-derived proteins. Solein is created using elements from the air—CO2, water, nitrogen—and electricity. This single-cell protein is cultivated through gas fermentation, essentially deriving edible calories from hydrogen-oxidizing microbes.
Butterfly Ventures is a seed-stage focused VC in the Nordics, investing in deep tech, hardware, and hardware interfacing software. The company prefers to get involved with companies early on; 80% of Butterfly Ventures portfolio companies don't have any revenue at the time of their entry. Butterfly Ventures was founded in 2012 and ever since then it has been one of the most active early stage VCs in the region. The company has offices in Oulu, Helsinki and Stockholm.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: Finland, Sweden, Norway
Investor stats
- Total investments: 91
- Round size: Seed $224k–$2.2M; Pre-Seed $110k–$4.3M; Venture - Series Unknown $1.2M–$6M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — raised $49M in 2022
Portfolio highlights
- DREV — DREV is a cleantech company manufacturing contamination control solutions for the world’s most advanced manufacturing facilities.
- Zenniz — Zenniz is an ITF approved game tracking solution that provides real-time info, such as automated line calling, stroke and serve speeds, shot charts, match statistics and more. Players and coaches at all levels can use Zenniz on and off the court to help improve their game. For tennis clubs, Zenniz is an easy and cost-effective way to upgrade to thenext level. Due to a new, innovative sensor technology, they’ve been able to keep the cost to a minimum, making Zenniz accessible for all clubs, coaches and players.
- Polar Light Technologies — Polar Light Technologies focuses on developing the next generation of Nano and micro LED technology.
Lifeline Ventures is one of the world's highest performing venture funds. Founded by serial entrepreneurs, Lifeline partners closely with resilient founders from day one — supporting them with funding, talent, and everything it takes to build category-leading companies. The fund is sector-agnostic and seeks to make inception to Series A investments. Lifeline Ventures was founded in November 2009 and is based in Helsinki, Finland.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Finland, United States, United Kingdom
Investor stats
- Total investments: 208
- Round size: Seed $580k–$5.4M; Series A $2.8M–$22M; Venture - Series Unknown $430k–$11M
- Lead/follow: 38% lead, 62% follow
- Last fund: Likely actively investing — fresh fund, raised $464M in 2025
Portfolio highlights
- Verda — Verda provides a full-stack AI cloud platform for the development, training, and deployment of AI models. Its services include GPU instances, instant clusters, serverless containers, managed storage, and other cloud infrastructure powered by NVIDIA hardware. Verda also operates an AI Lab focused on large-scale training, inference optimization, reinforcement learning, and AI systems engineering. Its platform serves AI developers and organizations across the full AI lifecycle, from prototyping to scalable inference.
- Thor Dynamics — Headquartered in Orlando, Florida, with a European base in Finland, Thor Dynamics specializes in directed energy systems for defense against drones and drone swarms. The company’s innovative solutions are available worldwide to protect critical infrastructure and enhance national security. Laser Armor™ is a complete directed energy counter-dronesolution. Utilizing advanced radar and optical systems it can detect, track, and target hostile targets. High-power directed energy from Thor’s Laser Engines then eliminates the threat in seconds. Multiple safety systems ensure accurate target identification and minimal collateral damage.
- Coherence Quantum — Coherence Quantum is a quantum hardware company that creates integrated cryogenic signaling and control platforms designed for solid-state quantum computers.
Finnish Industry Investment Ltd is a government-owned investment company. It invests the proceeds accrued from the privatisation of state-owned companies in stimulating the growth and internationalisation of Finnish businesses. Finnish Industry Investment invests in venture capital funds and directly in growth companies, together with private co-investors. The targets are in all sectors. Capital investments are needed for financing the growth of investee companies, and for spin-offs, major industrial investments, and sector and corporate restructurings. The investments of Finnish Industry Investment amount to over MEUR 570
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Series A, Series B
- Geography: Finland, United States, Switzerland
Investor stats
- Total investments: 154
- Round size: Series A $2.4M–$46M; Series B $3.1M–$40M
- Lead/follow: 16% lead, 84% follow
- Last fund: May invest from a new fund soon — raised $177M in 2017
Portfolio highlights
- Vexlum — VECSELs Novel semiconductor lasers for high-impact applications in quantum technology, medicine and semiconductor industry.
- Verda — Verda provides a full-stack AI cloud platform for the development, training, and deployment of AI models. Its services include GPU instances, instant clusters, serverless containers, managed storage, and other cloud infrastructure powered by NVIDIA hardware. Verda also operates an AI Lab focused on large-scale training, inference optimization, reinforcement learning, and AI systems engineering. Its platform serves AI developers and organizations across the full AI lifecycle, from prototyping to scalable inference.
- Kasvu Therapeutics — Kasvu develops first and best-in-class small molecule neuroplastogens for diseases where neuronal connectivity is altered
Finnvera makes direct investments in early-stage enterprises through Seed Fund Vera Ltd. Finnvera's goal is to cover shortcomings existing on the market between product development funding and private equity investments. Finnvera does not compete with private financiers; instead, it strives to supplement the financial market. Finnvera's investments enable, start and accelerate growth and internationalisation among investment targets. Enterprises are developed to make them attractive targets for further financing by other investors and industrial actors. Investments are made in technology enterprises at an early stage and in technology-intensive or innovative service enterprises that have potential for developing into international growth enterprises. Finnvera is also known as a specialised financing company owned by the State of Finland. It provides its clients with loans, guarantees, venture capital investments and export credit guarantees.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Finland, United States, Chile
Investor stats
- Total investments: 96
- Round size: Seed $250k–$2.3M; Series A $1.8M–$23M; Venture - Series Unknown $228k–$11M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- ARAUCO — ARAUCO is a diversified global company in the forestry industry. They use world-class technologies and processes throughout the value chain. They are present in the forestry, pulp, timber, panels and renewable energy businesses.
- eMabler — EMabler is an EV charging infrastructure software company that develops an API-first platform used by businesses to operate, manage, and scale electric vehicle charging networks. It provides a centralized system for charge point management, billing, pricing, roaming, and energy optimization, allowing operators to control large networks of EVchargers from a single platform. The software connects charging hardware with business systems such as CRM, payment, and energy management tools through open APIs and a large library of integrations. The company focuses on enabling enterprises, such as energy utilities, parking operators, and retail businesses, to embed EV charging directly into their existing services and digital platforms rather than building standalone charging systems. This includes white-label solutions where charging is integrated into a company’s own app or customer experience under its brand.
- CHAOS — At CHAOS, we strive to democratize data and harness the power of AI and cutting-edge technology, delivering transformative location insights that empower decision-makers to design more liveable cities- sustainable, human-centered where the quality-of-life soars.
Innovestor is an active Finnish investment manager, focusing on venture capital, real estate, and energy storage. We also offer corporate venturing services.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Venture - Series Unknown, Pre-Seed
- Geography: Finland, Sweden, Denmark
Investor stats
- Total investments: 98
- Round size: Seed $477k–$4.5M; Pre-Seed $204k–$2M; Venture - Series Unknown $529k–$5.1M
- Lead/follow: 55% lead, 45% follow
- Last fund: Likely still investing — raised $33M in 2023
Portfolio highlights
- Khoy — Khoy Company is a furniture company focused on designing and developing comfortable, user-friendly, and sustainable sofa beds. It combines functionality, comfort, and modern design to create versatile furniture for everyday living, with an emphasis on sustainability and space efficiency.
- AnaCardio — AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility and aims to improve clinical outcomes in heart failure.
- Bahn Express — Bahn Express is a global car transportation company that supports independent contractors while offering quick and easy auto shipping throughout Europe.
Voima Ventures’ mission is to solve major global problems by combining science, entrepreneurship, and value adding capital. They shed light on the ideas and technology which require time and courage to build. Industry domains include bio and new materials, medical technologies and life sciences, imaging and optics, IoT and electronics, robotics, software & ICT and AI. In addition, Voima Ventures has invested in more than 30 deep tech startups, including companies like Solar Foods, Infinited Fiber Company, and Dispelix. Cornerstone investors are VTT Technical Research Centre of Finland and European Investment Fund (EIF), backed by Finnish private and institutional investors.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland, Sweden, Norway
Investor stats
- Total investments: 62
- Round size: Seed $1M–$5.9M; Pre-Seed $464k–$2.1M; Series A $3.9M–$30M
- Lead/follow: 65% lead, 35% follow
- Last fund: Likely still investing — raised $108M in 2023
Portfolio highlights
- Reduciner — Reduciner's vision to turn industrial CO₂ emissions from a liability into a valuable resource. Its technology converts captured carbon dioxide and biochar into valuable feedstocks such as carbon monoxide and activated carbon, enabling circular carbon use in emissions-intensive industries. Reduciner combines strong scientific expertise withindustrial applicability across sectors such as cement, steel, and chemicals. Its electricity-driven process allows industries to reduce emissions without major changes to existing infrastructure, offering a resilient and cost-competitive way to reduce carbon dependency while creating new value from CO₂ emissions.
- TheStorage — Flexible industrial heat electrification and scalable energy storage. TheStorage offers cost efficient, sustainable grid scale energy storage that can discharge heat, steam or CHP.
- Aventix — Aventix is a bioanalytics/life-science instrumentation company that develops sensor-based laboratory tools.
Founded in 2016, Icebreaker has invested in over 50 fast-growing tech startups built by domain expert founders from companies like Rovio, Nordea, Pipedrive, Eniram, IBM and BCG. In addition to the fund, Icebreaker also runs a community of more than 1000 founders and pre-founders with 5+ years of relevant industry experience and the will to start, build or join strong tech companies. With the initial ticket sizes of €150k - 800K Icebreaker provides enough funding for companies to get to a position of strength and avoid post-accelerator limbo without having to resort to disreputable sources of capital and unfriendly deal terms.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Pre-Seed, Seed, Series A
- Geography: Finland, Sweden, Estonia
Investor stats
- Total investments: 144
- Round size: Seed $409k–$5.4M; Pre-Seed $110k–$1.3M; Series A $3.1M–$25M
- Lead/follow: 56% lead, 44% follow
- Last fund: May invest from a new fund soon — raised $24M in 2021
Portfolio highlights
- Cachet — Adaptive insurance solutions for micromobility, car-sharing and gig work platforms in 16 countries. Feel in control of risk and handle claims in one system.
- Oplane — Connect your repo. See and fix your vulnerabilities in minutes. AI-powered threat modeling - no consultants, no weeks of docs.
- Cota Robotics — Cota Robotics deploys general-purpose robots in retail stores through a Robot-as-a-Service model, integrating with existing environments without requiring changes to store layouts or infrastructure. The company automates shelf replenishment, inbound handling, and order picking using human-in-the-loop teleoperation, with autonomy increasing asdeployment data trains its models.
Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: Finland, Sweden, United States
Investor stats
- Total investments: 180
- Round size: Seed $549k–$6M; Series A $1.3M–$17M; Series B $1.3M–$25M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely still investing — raised $140M in 2022
Portfolio highlights
- Lassie — Lassie is the first proactive and preventive pet insurance company that wants to help pet owners take better care of their pets
- Capalo AI — We maximize the value of your energy storage systems. Now and in the future.
- Algorithmiq — Algorithmiq utilizes its expertise in quantum information, complex systems, and computational physics to develop algorithms to develop new and effective drugs, solve problems in life sciences, and discover new materials.
Springvest is a listed growth equity investor connecting Finnish technology companies with both domestic and international capital. We typically raise €5–12 million rounds from our Finnish investor base and lead larger rounds of up to €50 million together with international co-investors. We remain a committed minority shareholder in every company we back.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Venture - Series Unknown, Seed
- Geography: Finland
Investor stats
- Total investments: 25
- Round size: Seed $1.6M–$7.6M; Series A $3.6M–$53M; Venture - Series Unknown $4.7M–$31M
- Lead/follow: 72% lead, 28% follow
Portfolio highlights
- Desentum — Allergen immunotherapy that is effective, safe, patient-friendly and approved by the regulatory authorities.
- Volare — Refining food, beverage and agricultural sidestreams into protein, oil and fertilizers. Sustainable Black Soldier Fly Protein & Oil for Pet Food and Aquafeed from Finland.
- CurifyLabs — CurifyLabs enables 3D printed personalized medicines in pharmacies and hospitals. Always close to the patient.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Reaktor Ventures they invest in seed stage companies and helps them to create markets.
Show more...Investment focus
- Industry: Software, Internet, E-Commerce
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland, Germany, United States
Investor stats
- Total investments: 60
- Round size: Seed $151k–$2.1M; Pre-Seed $158k–$1.8M; Series A $1.7M–$6.8M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Valpas — Valpas is the hygiene protocol that reassures your future guests and keeps your hotel clean from the most uncontrollable: bed bugs
- allies.digital — Allies is a match-making platform curating businesses with IT-, digital and creative agencies. No more miss-matches when buying IT & creative services.
- StarBerry Games — StarBerry Games GmbH is a mobile games company based in Berlin, Germany. The company develops free-to-play casual mobile games and is best known for its games Merge Mayor and Idle Coffee Corp.
Organizing and investing in a global army of entrepreneurs committed to achieving health moonshots
Show more...Investment focus
- Industry: Health Care, Medical, Wellness
- Stage:Seed, Venture - Series Unknown, Pre-Seed
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 407
- Round size: Seed $100k–$3.5M; Pre-Seed $20k–$854k; Venture - Series Unknown $150k–$15M
- Lead/follow: 3% lead, 97% follow
- Last fund: May invest from a new fund soon — raised $31M in 2018
Portfolio highlights
- AvoMD — AvoMD is reimagining clinical decision support with interactive point-of-care software, available standalone and via EHR integrations, and seamless content building tools.
- Hidoc Consult — Hidoc Consult: Boost your well-being with free consultations, 24/7 access to quality healthcare, complete privacy, user-friendly, and a trusted network of HCPs
- NEXT Life Sciences — NEXT Life Sciences is developing the revolutionary Plan A™ procedure to bring the only scientifically proven technology in the category - Vasalgel® - to market.
The Redstone team is an international and diverse group of serial entrepreneurs, investors, investment professionals, tech analysts and data scientists.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Finland, Switzerland
Investor stats
- Total investments: 179
- Round size: Seed $460k–$7.8M; Pre-Seed $1M–$4.4M; Series A $1.7M–$17M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely actively investing — fresh fund, raised $29M in 2026
Portfolio highlights
- FermLabs — Ferm Labs ingredient startup specializing in proprietary, high-yield bioprocessing platforms.
- LimX Dynamics — Zhuji Dynamics is a general-purpose footed robot company that focuses on the R&D and manufacturing of sports intelligence and footed robots
- Zhuji Dynamics — Zhuji Dynamics is a general-purpose footed robot company that focuses on the R&D and manufacturing of sports intelligence and footed robots
We partner with founders to transform unseen scientific discoveries into future breakthroughs, jointly moving businesses, people, and the world forward.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Diagnostics
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland, Sweden, Germany
Investor stats
- Total investments: 19
- Round size: Seed $373k–$4.6M; Pre-Seed $380k–$837k; Series A $2.9M–$34M
- Lead/follow: 79% lead, 21% follow
- Last fund: Likely still investing — raised $34M in 2024
Portfolio highlights
- MuRay — MuRay develops non-destructive 3D inspection technology powered by an artificial muon beam that is generated on demand via a compact laser-plasma accelerator. The startup's value proposition centers on replacing slow cosmic muon tracking with an active, rapid accelerator platform that yields 100x deeper material penetration than conventional X-rays. Its technology enables high-resolution, internal structural analysis of massive, high-density elements across industrial aerospace, automated security, and medical imaging applications.
- mu-ray.tech — MuRay Tech generates a controlled muon beam to image inside solid metal and 3D printed pieces. Non-destructively. In minutes.
- Kasvu Therapeutics — Kasvu develops first and best-in-class small molecule neuroplastogens for diseases where neuronal connectivity is altered
WE HELP YOU TO GROW FASTER!
Show more...Investment focus
- Industry: Software, Information Technology, Internet
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Finland, United States, United Kingdom
Investor stats
- Total investments: 76
- Round size: Seed $87k–$1.3M; Series A $2M–$14M; Venture - Series Unknown $100k–$4M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Pebble — Meet Pebble Flow: a 100% electric RV with active towing, auto-hitching and infinite off-grid power via our Extended Solar upgrade. Reserve now.
- LiveMusicStage — We're a live music venue online. We let you to actually take part in the shows and interact with the bands while they're playing. You're always in the front row
- BetterDoctor — Our provider network software solutions & services provide unmatched tools & insights for you. Discover how you can measure, manage, monitor & model.
Almaral provides risk management advice long-term strategy development budgeting operational function setup legal support early-stage sales and marketing function setup, and commercialization.
Show more...Investment focus
- Industry: Medical Device, Health Diagnostics, Software
- Stage:Seed, Convertible Note, Venture - Series Unknown
- Geography: Finland
Investor stats
- Total investments: 6
- Round size: Seed $832k–$2.9M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Fepod — Fepod Oy Ltd develops a point-of-care diagnostics platform for rapid blood concentration measurement of pain medicine and other markers. Using a mobile phone, portable reader, and disposable sensors, it delivers quick, accurate results in minutes, enabling timely treatment decisions in acute care settings. The company aims to be the #1 acute carePOC diagnostics platform by 2030.
- Marginum — Pioneering the next-generation quantitative surgical techniques.
- Moncyte Health — Unique technology and novel data for personalized and optimal treatment of high cholesterol
Sitra is the venture capital investment arm of Sitra specializing in investments in seed, start-ups, early stage opportunities, and other funds. The firm invests through its three programmes namely, Health Care Programme, the Food and Nutrition Programme, and the Environmental Programme. Within the Health Care Programme, investments are focused on companies engaged in paper-free health care, seamless services, decentralised specialised health care, and support services. Within the Food and Nutrition Programme, investments are made in enterprises engaged in the food and nutrition sector, including value-adding upgrading of raw materials and new applications and service concepts in food and nutrition technology.
Show more...Investment focus
- Industry: Health Care, Biotechnology, CleanTech
- Stage:Venture - Series Unknown, Seed
- Geography: Finland, The Netherlands
Investor stats
- Total investments: 10
- Round size: Venture - Series Unknown $1.5M–$3.4M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Naava — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
- Headai — Headai Space is here. Early access now open.
- SET Ventures — SET propels founders from early growth to European scale. We invest in and grow the solutions powering the digital energy economy.
VTT is a powerhouse of technology development and scientific research. Many of the most significant Finnish technology start-ups were brought to life at VTT. Do you want to invest in ongoing ventures?
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Electronics
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Finland
Investor stats
- Total investments: 24
- Round size: Seed $460k–$3.3M; Series A $1.8M–$14M; Venture - Series Unknown $1.5M–$9.2M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Dispelix — See-through, full color waveguide combiners for a wide range of XR applications. From near-eye to head-up.
- Solar Foods — Solar Foods is a food-tech startup that specializes in testing a technology that uses electricity to produce hydrogen which is combined with carbon dioxide, water, vitamins, and minerals to feed and grow microbial biomass that can be used as edible protein. The industrial biotech startup develops a protein called Solein, a nutritious, sustainablesubstitute for animal-derived proteins. Solein is created using elements from the air—CO2, water, nitrogen—and electricity. This single-cell protein is cultivated through gas fermentation, essentially deriving edible calories from hydrogen-oxidizing microbes.
- Infinited Fiber Company — Infinited Fiber Company is a Finnish biotech founded in 2016 to commercialize a breakthrough recycling technology that can turn cellulose-rich raw materials – like cotton-rich textile waste, used cardboard, or wheat or rice straw – into high-quality textile fibers with the look and feel of cotton. The patented technology has been validated byleading brands and is ready to be scaled. Infinited Fiber Company won the Europas 2020 Hottest Sustainability Tech Award, and was listed on the Global 50 to Watch by Cleantech Group in 2019. In 2016 Infinited Fiber Company was selected into WWF’s Climate Solver network. The company is headquartered in Espoo, Finland.
We partner with deep tech and brand-driven companies obsessed in challenging category norms. The Nordics are our home, but we take on a global front in spotting the unexpected - from B2B to B2C, with a sweet spot for scientific advances, strong IP, and customer understanding that looks beyond convention. We invest in early stage companies: from their inception to series A and beyond. We share in the vision of founders as champions and challengers, drawing on our experiences from scaling some of the strongest tech companies ourselves.
Show more...Investment focus
- Industry: Software, E-Commerce, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: Finland, Norway, Denmark
Investor stats
- Total investments: 104
- Round size: Seed $948k–$8.3M; Pre-Seed $578k–$2.7M; Series A $3.5M–$37M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $106M in 2024
Portfolio highlights
- Aavuus — Aavuus is building a global network of ground-based laser stations to detect and track space debris with high precision.
- Quanscient — Quanscient develops multiphysics simulation software utilizing quantum computing algorithms to improve simulation technology. Its Computer Aided Engineering (CAE) platform integrates a unique combination of cloud-native multiphysics solvers, advanced cloud computing, and future quantum integration. The platform also offers engineers over ahundredfold increase in simulation throughput to enable fully digital R&D processes, addressing complex technology challenges in industries like fusion energy, 6G/7G, advanced semiconductors, biomedical, automotive, and aerospace.
- Volare — Refining food, beverage and agricultural sidestreams into protein, oil and fertilizers. Sustainable Black Soldier Fly Protein & Oil for Pet Food and Aquafeed from Finland.
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Denmark, United Kingdom
Investor stats
- Total investments: 415
- Round size: Series A $9.5M–$133M; Series B $15M–$135M; Series C $35M–$118M
- Lead/follow: 40% lead, 60% follow
- Last fund: May invest from a new fund soon — raised $165M in 2018
Portfolio highlights
- Windward Bio — Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with serious immunological diseases.
- SCHOTT Poonawalla — SCHOTT Poonawalla is a manufacturer of pharmaceutical containers, made of neutral glass tubing. The company provides parenteral packaging systems crafted from tubular glass, serving the pharmaceutical industry with a broad range of products including vials, pre-fillable syringes, ampoules, and cartridges.
- Vantia Therapeutics — Vantia Therapeutics is an emerging pharmaceutical company developing novel, small molecule drugs targeting large areas of unmet medical need. Its strong clinical pipeline includes VA106483 for nocturia and VA111913 for dysmenorrhoea, which directly target indications that together affect many millions of people, are poorly treated and representbillion dollar markets. Vantia's strategy is to develop its proprietary drug candidates through Phase II clinical testing and then commercialise through partnerships. The Company was founded in 2008 and is backed by specialist life science investors Novo A/S, SV Life Sciences and MVM Life Science Partners.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Some call you founders. We call you Superheroes. Seed stage VC investing in insight-driven startups in Finland and the Baltics. Tickets 100 K€ - 1000 K€.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: Finland, Lithuania, Estonia
Investor stats
- Total investments: 105
- Round size: Seed $228k–$2.6M; Pre-Seed $114k–$1.8M; Venture - Series Unknown $1.6M–$7.3M
- Lead/follow: 57% lead, 43% follow
- Last fund: Likely actively investing — fresh fund, raised $41M in 2025
Portfolio highlights
- KineDB — KineDB develops a dual-purpose database engine capable of operating as an embedded system on mobile devices or clustered within cloud data centers. The technology natively integrates replication, data history tracking, and merge logic to support continuous offline writing and automatic data synchronization upon reconnection. It utilizes a peer-to-peer data balancing architecture to eliminate traditional sharding and replica configuration processes. Every data write is permanent and addressable, providing an built-in audit trail that allows versioning and rollbacks. Additionally, the system writes logs directly to cloud object storage, enabling operational servers to function ephemerally without local state management. KineDB recently closed a cross-border pre-seed investment round with Superhero Capital, NGL and the founders of Formalize. Start-up lawyer Michael Pilegaard from Mace Legal acted as legal counsel to KineDB during the pre-seed investment round.
- Bilt.me — Describe your app idea and Bilt builds it. Preview on your phone, publish to the App or Play Store when you're ready.
- Guideless — Guideless turns any browser workflow into a polished, AI-narrated video guide in minutes. No screen recording, no tedious editing. Just turn on our Chrome extension, click through your process as you normally would, and instantly get a share-ready guide.Use cases: Product walkthroughs, customer onboarding, employee training, and supportdocumentation.Key features: - AI-written narration and natural voiceover. - Smart zooms and highlights for clarity. - Built-in captions for accessibility. - Always consistent and on-brand. - Shareable URLs, embed codes, and export to MP4How it works: - Add the Chrome extension. - Capture your workflow. - Share your guide.Privacy built-in: Your guides and data are never used to train AI models and are securely encrypted.Check https://guideless.ai/gallery and get inspired with curated guides showcasing workflows, product demos, and tutorials across every use case.
Oy Hammaren & Co Ab provides financial services and insurance activities.
Show more...Investment focus
- Industry: Health Care, Wellness, GreenTech
- Stage:Venture - Series Unknown, Angel, Series A
- Geography: Finland
Investor stats
- Total investments: 4
- Round size: Venture - Series Unknown $1.5M–$7.8M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Naava — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
- Heltti — Heltti redefines occupational healthcare and well-being services with technology and a subscription model. Heltti develops the most lovable digital health care systems. Heltti is a Finnish occupational health care company founded in 2013. It is owned by its employees and a handful of renowned Finnish investors, such as Risto Siilasmaa.
- NaturVention — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
The University of Helsinki has the widest range of disciplines in Finland. It was established in Turku in 1640, but was transferred to Helsinki in 1828. The number of faculties is eleven. There are 35,000 degree students and 7,900 staff. The number of degrees taken each year is an average 5,000, of which about 470 are doctorates. The University concentrates on high-level scientific research and researcher education. Scientific research is also the basis of the teaching provided by the University. The University operations support the development of society, as well as business and industry. University representatives offer their competencies for the benefit of society through a number of positions of trust and expertise. The results produced by the research and teaching carried out at the University have been widely acclaimed. The University participates in more than half of the national Centres of Excellence in Research, elected by international scientific panels. The University of Helsinki has been invited to be a member of the League of European Research Universities, a co-operation body for the leading European research universities. According to international expert panels, also the teaching provided by the University of Helsinki is of a high European level. The University has strong international connections. It has some 80 co-operation agreements with universities on different continents. The University researchers are in great demand as experts in international scientific communities, meetings and publications. The University is bilingual, but in addition to Finnish and Swedish teaching is also provided in English. Besides Helsinki, the University has operations at 20 localities throughout Finland.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed, Series A, Pre-Seed
- Geography: Finland, Luxembourg, United States
Investor stats
- Total investments: 12
- Round size: Seed $54k–$7.4M; Pre-Seed $837k–$1.2M; Series A $2.9M–$34M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- Ferrivia — Ferrivia on suomalainen palvelu, joka keskittyy raudanpuutteen ja rautaterveyden mittaamiseen.
- Avenue Biosciences — From biotechnology tools to therapy discovery and development: Our platform enhances production yield and the quality of your end product.
- Kasvu Therapeutics — Kasvu develops first and best-in-class small molecule neuroplastogens for diseases where neuronal connectivity is altered
Nidoco AB is a Swedish investment company whose strategy is to create long-term value through active ownership of public and private companies.
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Seed, Venture - Series Unknown, Pre-Seed
- Geography: Finland, Sweden, Estonia
Investor stats
- Total investments: 29
- Round size: Seed $327k–$2.6M; Pre-Seed $700k–$759k; Venture - Series Unknown $1.5M–$60M
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- Betolar — Betolar is a materials technology company that develops circular economy solutions for the mining, metals, and construction sectors by transforming industrial sidestreams and waste materials into valuable products. Its technologies support the production of low-carbon, cement-free construction materials and enable the recovery of critical andstrategic metals from industrial waste streams. The company provides material analysis, consulting, and recipe optimization services, utilizing digitalization, data platforms, and artificial intelligence to support research, development, and industrial applications. Betolar's solutions are designed to help reduce carbon emissions, decrease reliance on virgin raw materials, and improve the utilization of industrial byproducts. Its activities span construction materials, metal extraction technologies, and circular material solutions that support more resource-efficient industrial processes.
- TactoTek — Set your imagination free and create user experiences with the help of sustainable smart molded structures.
- CHAOS — At CHAOS, we strive to democratize data and harness the power of AI and cutting-edge technology, delivering transformative location insights that empower decision-makers to design more liveable cities- sustainable, human-centered where the quality-of-life soars.
Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Pre-Seed, Seed, Series A
- Geography: United States, Singapore, Australia
Investor stats
- Total investments: 2394
- Round size: Seed $159k–$4.6M; Pre-Seed $100k–$611k; Series A $4.1M–$29M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely actively investing — fresh fund, raised $7.5M in 2026
Portfolio highlights
- Praktiki — Praktiki is the AI platform for medical education: expert-led, case-based 5-minute modules HCPs love, built in hours and measured for behaviour change.
- ReportsAI — ReportsAI is an impact operating system that automates data collection and reporting for NGOs and industry to ensure audit-ready compliance.
- Plouton AI —
Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, Switzerland, United Kingdom
Investor stats
- Total investments: 247
- Round size: Series A $5.1M–$81M; Series B $11M–$107M; Series C $9M–$75M
- Lead/follow: 26% lead, 74% follow
- Last fund: May invest from a new fund soon — raised $200M in 2009
Portfolio highlights
- Kynexis — Kynexis is leading the way in precision medicine, focusing on the treatment of cognitive impairment associated with schizophrenia (CIAS). Explore our innovative approach and our dedication to improving the lives of millions globally.
- Visiogen — Visiogen, Inc. is an ophthalmic medical device company specializing in the development of new vision alternatives for patients with cataracts, with and without presbyopia. As part of this mission, Visiogen created the Synchrony dual optic accommodating *intraocular lens (IOL)* for use in the surgical treatment of these conditions.The device isdesigned to provide patients with near, intermediate and distance vision in a seamless continuum without the need for glasses or contact lenses. To eliminate lens handling during surgery, the Synchrony dual optic IOL is provided in a pre-loaded injector. This patented technology has been approved in Europe with a CE Mark designation and is currently undergoing clinical trials in the United States.
- Rein Therapeutics — Harnessing fibrosis, unleashing life
HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A
- Geography: United States, Sweden, France
Investor stats
- Total investments: 141
- Round size: Series A $6M–$73M; Series B $12M–$92M
- Lead/follow: 26% lead, 74% follow
- Last fund: Likely still investing — raised $179M in 2024
Portfolio highlights
- Neobiomics — Neobiomics is a Swedish life-science company that develops nutritional products for preterm infants and neonatal care. Its best-known products include ProPrems® and NeoMega36®.
- AMRA Medical — AMRA Medical is a digital health company transforming medical research and clinical care using rapid whole-body MRI technology.
- Ultragenyx Pharmaceutical — Ultragenyx is focused on developing first-ever approved treatments for rare and ultrarare diseases and moving the rare disease community forward.
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by great entrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Switzerland
Investor stats
- Total investments: 190
- Round size: Seed $2.4M–$24M; Series A $5.8M–$56M; Series B $13M–$100M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Mueon — semiconductor-based systems for AI and hyperscale computing
- Nouscom — Nouscom is a next-generation immunotherapy company developing genetic cancer vaccines and oncolytic viruses..
- iOnctura — Our mission is to develop high impact, low disruption therapies that extend healthspan. We do this by disrupting the dynamic interplay at the heart of the
Pontos is a family owned Finnish private equity and real estate investment company operating in Finland, the Baltic States, and Portugal.
Show more...Investment focus
- Industry: Apps, Mobile, Content
- Stage:Venture - Series Unknown, Seed
- Geography: Finland, Estonia
Investor stats
- Total investments: 5
- Round size: Venture - Series Unknown $6.3M–$16M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Hintsa — Discover a better you, with methods proven in Formula 1 and Fortune 500.
- R8tech — R8 Jenny is AI HVAC technology for commercial real estate. It helps you achieve ESG goals while saving up to 30% in energy costs!
- Blueprint Genetics — We offer complete genetic testing and genetic diagnostics to medical professionals worldwide. Learn more about our winning clinical-grade NGS offering!
The Pharmacy Pension Fund offers insurance services. Their services include employment pension statement, secure message, applying for a pension, insurance matters, pensioner and beneficiary services, vocational rehabilitation travel reimbursement application, and certificate of pension.
Show more...Investment focus
- Industry: Health Care
- Stage:Venture - Series Unknown
- Geography: Finland
Investor stats
- Total investments: 3
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Nukute — Nukute is a medical device and services development company that intends to design, patent, and market medical devices and services related to sleep apnea. The company's sleep apnea screening and diagnostics solution includes two wireless wearable sensors, a tablet computer, and a cloud application. Wearable sensors record biosignals such asbreathing, blood oxygen saturation, heart rate and sleeping position to be analyzed in the cloud using a machine learning algorithm.Nukute was established in 2015 and is headquartered in Oulu, Finland.
- CurifyLabs — CurifyLabs enables 3D printed personalized medicines in pharmacies and hospitals. Always close to the patient.
- Koite Health — Koite Health develops medical equipment using antimicrobial photodynamic treatment. It is a health technology firm that pioneered the creation of light-activated antibacterial treatments and preventative measures for oral ailments. It uses LED lighting technology with the light-activated, antibacterial lumorinse mouthwash.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Takoa Invest is a Finnish family-owned investment company that owns and develops companies and properties with growth potential in Finland and abroad. Takoa Invest is a Finnish family-owned investment company. It owns and develops companies and properties with growth potential in Finland and abroad.
Show more...Investment focus
- Industry: Biotechnology, Mobile, Retail
- Stage:Seed, Series B, Angel
- Geography: Finland, Israel
Investor stats
- Total investments: 8
- Round size: Seed $490k–$1.7M; Series B $4.2M–$35M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Theranica — Theranica is a medical device company that has combined neuromodulation therapy with modern wireless technology to develop proprietary wearable solutions that address various medical conditions and disease states. The noninvasive and therapeutic 'smart' patches are controlled by a smartphone app to allow for personalized, portable, andaffordable care. The patch consists of a proprietary 'smart' chip that delivers electrical pulses to neuro-modulate the sensory nerves under the skin. The first application of the technology is for treatment of migraine headaches.
- Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
- Iiwari Tracking Solutions — Accurate UWB indoor positioning you can build your own applications on. Proven in care homes with Iiwari Care nurse call and staff duress.
Athensmed Oy
Show more...Investment focus
- Industry: Health Care, Health Diagnostics, Medical
- Stage:Seed, Series A
- Geography: Finland, Switzerland
Investor stats
- Total investments: 5
- Round size: Seed $1.1M–$4.3M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Biospectal — Measure and track blood pressure with only your phone camera and fingertip. With OptIBP, you can keep a diary of blood pressure, share BP, and take control of your heart health.
- Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
- Moncyte Health — Unique technology and novel data for personalized and optimal treatment of high cholesterol
Gorilla Capital helps ambitious startups grow with smart funding and support. Discover how our team invests in early-stage companies.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Pre-Seed, Seed, Venture - Series Unknown
- Geography: Finland, Sweden, Estonia
Investor stats
- Total investments: 80
- Round size: Seed $294k–$1.5M; Pre-Seed $149k–$680k; Venture - Series Unknown $1.1M–$2.1M
- Lead/follow: 65% lead, 35% follow
- Last fund: Likely actively investing — fresh fund, raised $49M in 2025
Portfolio highlights
- Amplifiles — Amplifiles is a PropTech startup that turns real estate listing photos into fully branded, high-quality videos in minute, no filming or editing required. Our video engine helps agents, photographers, and marketplaces boost engagement, generate more leads, and unlock new revenue streams.
- Comparables.ai — The leading M&A and valuation intelligence platform. Find +110% more relevant companies 10.5x faster. Access comprehensive financials, transaction data, and AI analysis on 370M+ companies worldwide.
- Nordic Information Control — Inventering och klassificering av information, automatiskt med Nordic Information Control Platform. Automatic Regulatory compliance.
European Investment Bank operates as the lending institution of the European Union, offering loans, guarantees, and technical expertise to governments, businesses, and financial institutions. The organization focuses on areas such as climate action, digital transformation, housing development, and security-related initiatives. Its activities include funding large-scale infrastructure, supporting technology development, and facilitating access to capital for emerging and established enterprises. The bank also delivers advisory support to structure projects, improve investment readiness, and align initiatives with policy objectives.
Show more...Investment focus
- Industry: Energy, Biotechnology, Health Care
- Stage:Debt Financing, Post-IPO Debt, Venture - Series Unknown
- Geography: France, Germany, Spain
Investor stats
- Total investments: 608
- Round size: Post-IPO Debt $16M–$587M; Debt Financing $16M–$355M; Venture - Series Unknown $8.7M–$110M
- Lead/follow: 82% lead, 18% follow
Portfolio highlights
- Impress — Impress – is European leading digital orthodontic DSO of new generationWe have a defensible model with the personal touch of an in-house orthodontist, true clinical expertise, and engaging directly with consumersImpress was founded in 2019 in Barcelona with the idea of combining the best of orthodontic tradition with the most innovativetechnology in the sector. From the very beginning the vision of the Impress founders was to introduce a different business model with a strong focus on medical experience and digitalization. The company is transforming the oral healthcare industry by developing its own chain of orthodontic clinics, which are characterized by their disruptive design and modern patient experience. The founders decided to build a medical company with the personal touch of in-house orthodontists, face-to-face care, and unique clinical expertise, where the proper implementation of business processes and digitalization are at the core.In less than 2 years, Impress has managed to position itself as the European leader in the orthodontic sector, has treated more than 22.000 smiles and already has a presence in more than 80 European cities. Its innovation and quality have earned it recognition from Sifted as one of the fastest growing HealthTech companies in Europe in 2020.
- Santander Brasil — Banco Santander in Brazil, its largest division in Latin America and one of the world's most important, accounting for 50%.
- Dandara Solar Power SAE — Dandara Solar Power SAE is a special purpose vehicle, established to develop a major renewable energy and storage project in Upper Egypt. The entity oversees the development and operational construction of a 500 MW solar PV plant integrated with a 100 MWh Battery Energy Storage System. All electricity generated by the company is bound to be sold to the industrial manufacturer Misr Aluminum Company under a long term, take or pay power purchase agreement.
96 Normal 0 false false false EN-GB X-NONE X-NONE
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Seed, Series B
- Geography: Germany, Finland, The Netherlands
Investor stats
- Total investments: 13
- Round size: Series A $2M–$7.9M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- Fiagon — Fiagon develops clinical navigation systems that reimagine image guidance by improving the function of electromagnetic navigation. Fiagon's systems use electromagnetic tracking matrix algorithms and flexible pointer technology that indicates the position of the instrument used in the CT or MRI image data, allowing physicians to get accurateplanning, improve patient outcomes, and implementation of the operation.
- Meidrix Biomedicals — Meidrix Biomedicals is a medical biotechnology company that specializes in medical devices for cartilage repair. Meidrix Biomedicals also offers regenerative and biological medical products. Meidrix Biomedicals was founded in 2009 and was headquartered in Bayern, Germany.
- SurgicEye — SurgicEye designs intra-operative imaging and instrument navigation solutions for surgical procedures. It offers a navigated radio-guided surgery based on the handheld 3-D freehand SPECT imaging technology called the declipse SPECT open surgery, an intraoperative 3D imaging system for invasive sentinel lymph node biopsy called the declipse SPECTLaparascopy, and a mobile SPECT imaging solution with a high resolution on a small footprint called the declipse SPECT imaging probe. The company also advises clients on medical device development, requirement engineering and software specification for medical devices, software development for medical devices, testing of software for medical devices, and support in the design and conduction of clinical studies.Dr. Jörg Traub founded SurgicEye in 2008, with its headquarters in Munich in Germany.
cross-border, healthcare, life science, investment, VC, China, US
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Venture - Series Unknown, Seed
- Geography: Finland, United States
Investor stats
- Total investments: 5
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Marginum — Pioneering the next-generation quantitative surgical techniques.
- Elucida Oncology — Elucida Oncology focuses on transforming outcomes for patients with primary solid tumors and metastatic cancer. The company utilizes the novel target or clear capabilities of its ultra-small C-Dot cancer-targeting particle platform across diagnostic imaging, surgical, and a wide range of therapeutic applications.
- Bone Index Finland — Bindex® is – in addition to DXA devices – the only device that can be used for osteoporosis diagnostics with international guidelines (ISCD) and the Finnish Current Care Guidelines (04/2014).Bindex® is applied by measuring the cortical thickness of tibia. The results, combined with other patient data, are used to estimate the hip region’sbone mineral density. Bone mineral density values (g/cm2) are normally only received via the large DXA devices used in hospitals.Bindex®’s quickness and simplicity make its use possible in high volume risk group screenings. It makes the identification of an osteoporosis risk possible before the first bone fracture has even occurred. Thus, it both improves the patient’s quality of life and saves on public health care expenses.
Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. The business model is to: SELECT the most commercially attractive medical innovations; DEVELOP innovations to the stage where the greatest return on investment can be achieved; and COMMERCIALIZE the innovations through the sale of companies or out-licensing of products. Karolinska Development has developed a well-structured selection process to identify the most commercially attractive medical innovations screened by KIAB. Pharmaceutical development is a high-risk enterprise. In most cases, development projects fail because of side effects or insufficient efficacy. Successful selection of innovations is fundamental to Karolinska Development’s business model, which makes the inflow of new projects crucial. One key to success lies in selecting those innovations that can be developed from scientific findings to products and have significant commercial potential. To date, over 1,300 projects have been screened by KIAB. The portfolio companies are often founded together with the innovators and are initially operated as virtual companies with few or no employees. During the first six to twelve months, the companies normally have minimal fixed costs and technological development is outsourced. The innovator, who is often employed at an academic institution, normally participates as a board member and scientific advisor. The CEO of a portfolio company cooperates closely with a representative of Karolinska Development, who in most cases is also a board member of the company. The companies are capitalized to reach their next milestone, usually within a period of six to eighteen months. Development projects are continuously monitored, and those that do not meet their stipulated targets are discontinued. In the first three to four years, a portfolio company’s operating expenses are often limited to a few million Swedish kronor per year, which cover the cost of external studies and the salary of the staff. In subsequent years, Karolinska Development and other investors play an important role recruiting key expertise to the companies Karolinska Development intends to realize value by exiting portfolio companies or through out-licensing of projects. Such transactions (especially out-licensing) are often structured as single upfront payments followed by payments based on predetermined milestones and royalties on sales. Although Karolinska Development has a flexible exit strategy, pharmaceutical products are, for two reasons, preferably exited at Phase II. First a successful Phase II study indicates that the pharmaceutical has an effect on patients, which is an important value-enhancing factor when negotiating out-licensing or sales. Secondly, finalizing product development and undertaking Phase III clinical trials frequently requires very large patient populations. In many cases this requires much greater resources than those available at Karolinska Development but these can be found in established pharmaceutical companies. Several licensing deals were closed in 2011 involving projects with a similar focus and development phase to Karolinska Development's projects.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Venture - Series Unknown, Seed
- Geography: Sweden, Denmark, United States
Investor stats
- Total investments: 32
- Round size: Venture - Series Unknown $2.1M–$10M
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- BOOST Pharma — BOOST Pharma is developing BT-101, an off-the-shelf therapy for early intervention in children with severe osteogenesis imperfecta (OI).
- Modus Therapeutics — Modus Therapeutics is a Swedish drug development company developing sevuparin – a novel drug to treat people suffering from Sickle Cell Disease – a painful, inherited blood disorder affecting millions of people around the globe.
- Umecrine Cognition — Umecrine Cognition is a Swedish clinical-stage pharmaceutical company developing a novel class of drugs to treat neurological disorders of the brain.
First Fellow Partners is a private investment firm built on a founder-first philosophy. We invest only our own capital, backing bold, mission-driven technology entrepreneurs from idea to lasting impact.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: Finland, United States, Sweden
Investor stats
- Total investments: 78
- Round size: Seed $500k–$8M; Pre-Seed $256k–$1.7M; Series A $2.3M–$26M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- CRACI — CRACI records build dependencies, identifies releases affected by vulnerabilities, and tracks the response from triage to a fixed release.
- Endform — Run your Playwright tests 10x faster across isolated machines. Catch failures before they reach production and stop flaky tests from slowing your team down.
- Quanscient — Quanscient develops multiphysics simulation software utilizing quantum computing algorithms to improve simulation technology. Its Computer Aided Engineering (CAE) platform integrates a unique combination of cloud-native multiphysics solvers, advanced cloud computing, and future quantum integration. The platform also offers engineers over ahundredfold increase in simulation throughput to enable fully digital R&D processes, addressing complex technology challenges in industries like fusion energy, 6G/7G, advanced semiconductors, biomedical, automotive, and aerospace.
Cor Group management consulting firm serving Psychological, Educational, and Behavioral Services.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland
Investor stats
- Total investments: 6
- Round size: Seed $2.3M–$8.7M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Gosta Labs — Focus on care
- Adamant Health — Adamant Health’s unique technology to analyse Parkinson’s disease symptoms is based on over 15 years of academic research at the University of Eastern Finland. With the technology, clinicians have several days detailed visibility to the patient’s symptoms and is able to optimise the treatment accordingly. Pharma companies benefit from the objectiveand long-term RW data in their clinical and post market studies and can utilise it as complementary diagnostics tool for personalised medication.
- Nightingale Health — The most advanced health check for the health industry.
Nostetta Ventures is a venture capital company investing in growth companies mainly in the North Savo region.
Show more...Investment focus
- Industry: Health Care, Medical Device
- Stage:Seed, Pre-Seed
- Geography: Finland
Investor stats
- Total investments: 3
- Round size: Seed $1.1M–$2.9M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Marginum — Pioneering the next-generation quantitative surgical techniques.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!European Innovation Council and SMEs Executive Agency (EISMEA)
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Software
- Stage:Grant, Venture - Series Unknown, Seed
- Geography: Spain, Italy, United Kingdom
Investor stats
- Total investments: 3596
- Round size: Seed $53k–$800k; Grant $54k–$2M; Venture - Series Unknown $573k–$2.6M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- AGADE — Esoscheletri Agade | Il primo esoscheletro intelligente per lavoratori progettato per ridurre il rischio di disturbi muscolari delle spalle nella movimentazione manuale dei carichi.
- BroadBit Batteries — BroadBit is a technology company developing revolutionary new batteries using novel sodium-based chemistries to power the future green economy.
- Aenitis Technologies — We develop innovative devices for cells therapy processing using Acoustic Radiation Forces.
Kinled was founded in 1980 to retain the investment assets of the Aisher family.In 1990, the investment focus shifted to a portfolio of early stage investments applying Kinled’s company development experience alongside the endurance and passion of family owned investments together with the strategic focus of venture capitalists.Since then,Kinled has taken 8 companies to public markets and many more to successful trade sales at significant multiples.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A
- Geography: United Kingdom, United States, Switzerland
Investor stats
- Total investments: 133
- Round size: Seed $500k–$11M; Series A $2M–$43M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Esper — Esper is the first cloud-based platform to help governments proactively manage public policy with better data and transparency.
- Varda — Expanding the economic bounds of humankind with the world's first orbital manufacturing & reentry platform.
- PreComb — PreComb develops technologies to optimally adapt the therapies to each patient for difficult to treat cancers to increase the success rates in cancer therapy. Only an efficient use of healthcare resources can lead to a maximum improvement in the quality of life of patients.
Illusian is the Founder Office of people who have founded and scaled companies like Supercell, Zalando, Wolt, Aiven, Pigment, and Smartly. While the group is still busy running their businesses, they've aligned their networks, capital, and expertise to simultaneously support the next generation of builders.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: Finland, United States, Germany
Investor stats
- Total investments: 51
- Round size: Seed $2.6M–$9M; Series A $5.9M–$44M; Series B $35M–$90M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- CodeWords —
- Riff — Databutton is an online app builder that empowers the next generation of entrepreneurs and innovators. It enables anyone to create dynamic online apps in minutes by connecting to a growing array of sources, models, and integrations, or by utilizing their own datasets. 먹튀검증 https://muktts.net/
- NewOrbit Space — NewOrbit Space is a satellite manufacturing company. We engineer Earth's lowest orbiting satellites, at altitudes of 180km (3x lower than conventional LEO satellites) we enable better imagery resolution and telecommunication services from space.
We fund futurebreakthroughs
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A, Pre-Seed
- Geography: Finland, Sweden
Investor stats
- Total investments: 18
- Round size: Seed $482k–$8.2M; Pre-Seed $330k–$4.3M; Series A $8.3M–$45M
- Lead/follow: 22% lead, 78% follow
Portfolio highlights
- AlixLabs — AlixLabs is a Swedish semiconductor startup, founded in 2019.
- Anferra — Anferra specializes in hydrometallurgy, utilizing methods for resource-efficient recycling of steel industry waste into iron chloride.
- Freepress.ai — Freepress operates with an AI-driven virtual news editor that analyzes hundreds of thousands of publicly available and licensed articles from different countries.
We have been investing at the frontier of technology and science for over 30 years. We know what it takes to succeed.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 99
- Round size: Seed $1.1M–$7.7M; Series A $2M–$12M; Series B $5.1M–$30M
- Lead/follow: 40% lead, 60% follow
- Last fund: May invest from a new fund soon — raised $90M in 2016
Portfolio highlights
- Ledgy — Digitize your cap table, automate equity plans and simplify compliance. Find out how leading companies use Ledgy to empower their employees and engage investors.
- HeyJobs — Intelligent recruiting | more hires with performance marketing | only qualified candidates | fast recruiting success | over 1,500 companies use HeyJobs to find employees
- Tacalyx — Tacalyx develops therapeutics targeting cancer-specific carbohydrate antigens on the surface of metastatic malignant tumors where no satisfactory treatments exist.The name Tacalyx is derived from TACA (Tumor Associated Carbohydrate Antigen) and ‘lyx’ from the term Glycocalyx, the glycan-containing layer covering cells. Cancer cells differ fromnormal cells by displaying aberrant carbohydrate structures on their surfaces promoting metastasis, angiogenesis or suppression of the immune system. TACAs result from the aberrant glycosylation that is seen with transformation to a tumor cell and represent attractive targets for cancer treatment since they are displayed with high cancer specificity and enhance tumor virulence via the mentioned diverse mechanisms.
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 350
- Round size: Series A $7M–$70M; Series B $10M–$105M; Series C $12M–$100M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely actively investing — fresh fund, raised $755M in 2025
Portfolio highlights
- Odoo — From ERP to CRM, eCommerce and CMS. Download Odoo or use it in the cloud. Grow Your Business.
- Mironid — Google Analytics is a web analysis service provided by Google. Google utilizes the data collected to track and examine the use of www.mironid.com, to prepare reports on its activities and share them with other Google services. Google may use the data collected to contextualize and personalize the ads of its own advertising network.
- Forth Therapeutics — Forth Therapeutics is a biotechnology company dedicated to advancing precision treatments for fibrosis.
Metsola Ventures
Show more...Investment focus
- Industry: Medical, mHealth, Automotive
- Stage:Series A, Pre-Seed
- Geography: Finland
Investor stats
- Total investments: 3
- Round size: Series A $2.2M–$5.4M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Kaiku Health — Kaiku Health is a digital health company with a mission to improve quality of life through health data science. We have built an intelligent digital platform for monitoring patient-reported outcomes in several therapy areas, such as cancer care, fertility treatments and preventive health care. Its unique algorithms enable early interventions andpersonalized patient support. Currently over 30 European hospitals and clinics are using our platform to better monitor their patients, reducing manual work and allowing prioritization of clinical actions. This along with the capture and analysis of real-world data paves way for more personalized and effective care of each patient. The company, founded in 2012 by five software developers deeply passionate about health care technology, has now grown to team of 20+ dedicated employees. The company is backed by Reaktor Ventures, along with other venture capital funds and private investors, and is supported by Tekes – the Finnish Funding Agency for Innovation.
- RoadCloud — Use the worlds most accurate road condition data to your advantage. Real-time hyperlocal road weather data from your road network 24/7.
- Synoste — Globus Medical develops, manufactures, and distributes musculoskeletal device solutions. Learn about the implants and products we manufacture.
Broadview Ventures, Inc. (Broadview) was established in 2008 as a new program conceived by the Leducq family. Through Broadview, the trust will work to accelerate the development of promising technology in cardiovascular and neurovascular disease through targeted investment in and support of early stage technology ventures.The FoundationLeducq, based in Paris, France, is the beneficiary of a charitable trust. In order to further the Foundation Leducq's mission in cardiovascular and neurovascular disease, the trust has made funds available to Broadview to develop a program which will promote early state technology in these fields through investments, licensing agreements and consortium funding arrangements, as well as professional, management and consulting support.With this initiative the trust joins other leaders in the venture philanthropy movement in seeking creative solutions to the problem of what is commonly referred to as the 'translational gap', a significant component of which is a lack of funding at a critical moment in the development of new technology and science.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Seed, Debt Financing
- Geography: United States, Israel, Denmark
Investor stats
- Total investments: 66
- Lead/follow: no public data
Portfolio highlights
- Nyra Medical — MitraPlug has created a catheter-plug technology for repairing a leaky mitral valve in the heart.This adjustable device needs only a two-inch surgical incision and can be inserted directly into the heart. Then the cardiologist can use the catheter to adjust the size and position of the plug to correct the leakage. When correctly fitted, thecatheter is removed, and the incision is closed, leaving only a small scar.
- RapidPulse — RapidPulse, Inc. is a privately held medical device company that develops minimally invasive vascular products for ischemic stroke. The company is advancing the development of the RapidPulse™ Cyclic Aspiration System, which includes a novel aspiration pump to allow rapid and consistent removal of blood clots from the brain. RapidPulse is a spinoutof Syntheon LLC., a medical device incubator dedicated to developing innovative products in the medical device industry
- Cardiosense — Cardiosense offers a physiological waveform AI platform to develop predictive biomarkers for the detection and treatment of disease. Its platform leverages multi-modal sensors and industry-leading AI to develop predictive biomarkers for the detection and treatment of disease.
Samsung Venture Investment is plays the role of driving the discovery and development of new businesses and technologies.
Show more...Investment focus
- Industry: Information Technology, Software, Health Care
- Stage:Series A, Series B, Seed
- Geography: South Korea, United States, India
Investor stats
- Total investments: 138
- Round size: Seed $45k–$4.1M; Series A $1.7M–$28M; Series B $3M–$23M
- Lead/follow: 32% lead, 68% follow
Portfolio highlights
- N.THING — Established in January 2014, N.THING is a Seoul-based Agri-Food tech company leading innovation in agricultural products, by extension, in the farm-to-table food value chain by combining IoT technology and data. It developed the world’s first modular vertical farm ‘CUBE’ which is easy to expand. N.THING CUBE is a modularized farm with massproductivity where a dedicated OS provides the most optimized environment for each crop so as to create maximized efficiency. N.THING is the world’s first smart farming company that won the iF Design Award, Architecture in 2020. Also, it is a winner of Best of Innovation at the CES 2020 for its excellence in technology, which is the first ever in the agricultural field. N.THING is planning to expand its business on a large scale this year after it successfully completes the PoC process in the U.A.E. Our North American branch office located in New York. N.THING hopes to connect people to nature, things to things, people to things, and people to people through IoT technologies by creating Number of Things out of Nothing. .CUBE : CUBE is internet connected modular container vertical farm. It's an ultimate indoor farm which contains LED technology, real time monitoring system through IoT sensors, collected cultivation data, and upgradable software. We deliver the farm of the desired container form to the desired place.SQUARE : SQUARE is modular hydroponic kit. SQUARE can connect each module and share water. Users can connect as many as they want, grow greens and herbs, and make food great themselves. Each Square consists of four Pickcells, which contains special nutrient-rich sponge. With special sponge and hydroponic, it gives the most simple and effective gardening experience.Planty : Planty is the first Internet-connected social pot in the world. Planty gives pleasure to grow plants with your family, friend, and colleague. Planty enables the user to monitor the environmental information on temperature, soil moisture, and ambient light around plants and give water to plants any me or anywhere.Life : Life is a smart gardening journal aimed at the gardening sector. Plant lovers and gardeners are able to record their gardening activities and information and share them through Social Media. The user can easily insert weather data, location data, gardening activities, and plants’ events. Moreover, all the gardening data can be shared through social media.Sikmulsung: Sikmulsung is our show room to explore 'freshness' of our product and service. It is a place for everyone seeking for 'freshness' in visual, in texture, in taste, in flavor or even in atmosphere with, N.THING's in-store farm, exclusively made for Sikmulsung, special F&B's and our end products.
- MangoBoost — Data Processing Unit (DPU) is a next-generation server accelerator designed to orchestrate various intra-server devices (e.g., CPU, GPU, SSD, NPU, NIC). By maximizing the datacenter’s overall performance and cost efficiency, DPU is now considered as the most important HW/SW solution to realize the next-generation extreme-scale AI serverinfrastructure. However, despite its critical necessity from the datacenter and AI infrastructure, there is no market-leading DPU solution which can meet the customer’s actual demand due to its HW/SW complexity and the application/model heterogeneity. MangoBoost is currently the world’s most highly recognized DPU startup located in US and Korea. We provide the world’s most advanced and flexible DPU HW/SW solutions in order to fully satisfy the needs of various customers. Our DPU HW is fully composable by integrating its rich set of DPU features to construct our customer-optimal DPUs. At the same time, our DPU SW enables to seamlessly deploy the solution to any customer environment. As a result, our DPU solutions are considered very promising to realize the next-generation AI/datacenter infrastructure, and thus they are currently evaluated at various global-leading companies. MangoBoost was founded in early 2022 to commercialize 7 year of top-tier DPU research outcomes achieved at Seoul National University (e.g., many full-system DPU prototypes, many ISCA/MICRO/ASPLOS/OSDI/ATC papers). The current team consists of 45+ system engineers including ~20 top-tier PhDs from Carnegie Mellon University, Seoul National University, POSTECH, U Toronto, and ~20 industry experts from Intel, Microsoft, Samsung, and Naver.
- Aim Intelligence — Leading AI Security & Safety Solutions Provider - Specializing in AI Risk Detection, Mitigation, and Elimination through Advanced Red Teaming and Defensive Systems | Leading provider of AI Security, Safety, and Compliance solutions
Co-operative Tradeka is a consumer co-operative involved in the restaurant business and involved in investment activities.Co-operative Tradeka is a consumer co-operative founded in the year 1917. Nowadays, the Co-operative serves approximately 225 000 members. The Co-operative Tradeka is a management co-operative, which is the owner of TradekaGroup Ltd (98%) and Tradeka-services Ltd (100%) (responsible for the membership benefits of the Co-operative). The CEO of the Co-operative Tradeka is Perttu Puro, Master of Laws.Tradeka Ltd is the sole owner of Restel Oy (involved in the restaurant business) and Tradeka-invest Ltd (involved in investment activities) The CEO Tradeka Ltd is Perttu Puro, Master of Laws.
Show more...Investment focus
- Industry: Fruit, Gaming, Nutrition
- Stage:Angel, Pre-Seed
- Geography: Finland
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Vegemi — Vegemi is a free smartphone app that promotes eating fruits and vegetables through gaming. The software was designed with the entire family in mind, but especially to demonstrate youngsters the health advantages of fruits and vegetables in a way that motivates and inspires them.
Health Care VC funding in Finland at a glance
Stats across 470 deals from 322 investors.
Access all 322 VC funds in Finland Health Care startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Health Care VC Funds in Finland investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 322 VC funds investing in Finland Health Care startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!